ROTTERDAM, NETHERLANDS, June 2026 — Centrient Pharmaceuticals has announced the appointment of Genevieve Machin (Gen) as its new Chief People and Transformation Officer, reinforcing the company’s commitment to building a high-performance culture while advancing strategic transformation initiatives across its global operations.
In her new role, Genevieve will lead Centrient’s global people strategy and human resources function while driving enterprise-wide transformation programs designed to improve organizational performance, productivity, and long-term sustainable growth. The position combines responsibility for HR governance, talent strategy, organizational effectiveness, and operational excellence with business-led transformation initiatives that ensure the company is equipped with the capabilities, structure, and culture required to meet future growth objectives.
Genevieve joins Centrient Pharmaceuticals following her tenure as Chief Human Resources Officer at the NATO Support and Procurement Agency (NSPA), where she led the design, development, and implementation of human resources initiatives aligned with NATO’s broader people strategy. Her responsibilities spanned talent acquisition, talent management, diversity, equity and inclusion, workforce planning, employee engagement, organizational design, health services, and large-scale change management programs.
Prior to NSPA, she held senior leadership positions with Gates Corporation, serving as Vice President Human Resources EMEA and Senior Director Human Resources EMEA. In these roles, she provided strategic and operational HR leadership across the region, overseeing talent strategy, leadership development, organizational effectiveness, industrial relations, shared services expansion, workforce restructuring initiatives, and HR analytics across multiple countries.
Earlier, Genevieve served as Vice President Human Resources at CHAMP Cargosystems, where she was responsible for the end-to-end design and execution of the company’s global people strategy. She led initiatives across diversity and inclusion, employee engagement, HR technology transformation, talent management, compensation, workforce planning, and organizational development while serving as a member of the executive management team.
She also spent more than four years with PolyOne, where she held leadership roles including Director Human Resources EMEA and India and Associate Director Human Resources (EMEA and India). During this period, she led regional HR operations across multiple countries, supported business transformation initiatives, managed labor relations, negotiated collective agreements, and implemented leadership development and talent programs designed to strengthen organizational capability.
Her earlier career included senior human resources and total rewards leadership positions with Husky Injection Molding Systems, NAV CANADA, Bank of Montreal, Toronto Stock Exchange, and Nortel Networks, where she developed extensive expertise across compensation and benefits, workforce analytics, organizational design, talent management, leadership development, labor relations, employee engagement, and HR transformation.
Over a career spanning more than twenty-five years, Genevieve has built a reputation for successfully leading people and transformation agendas within complex multinational organizations. Her expertise spans talent development, organizational design, reward strategy, workforce planning, performance management, leadership capability building, change management, HR technology implementation, and large-scale business transformation. She is Prosci-certified in Change Management, PRINCE2 Agile certified, and brings significant international experience across Europe and North America.
Her appointment comes at a strategically important time for Centrient Pharmaceuticals as the company continues to strengthen its position as a global leader in sustainable antibiotics, statins, anti-fungals, and pharmaceutical ingredients. With growing global focus on healthcare resilience, supply chain security, and antimicrobial resistance, Genevieve’s leadership is expected to play a critical role in building the organizational capabilities required to support the company’s long-term mission and growth ambitions.
About Centrient Pharmaceuticals
Centrient Pharmaceuticals is a global business-to-business leader in sustainable enzymatic antibiotics, next-generation statins, anti-fungals, active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. With more than 1,800 employees worldwide, the company serves customers across the global healthcare ecosystem while supporting the reliable supply of essential medicines.
Founded more than 150 years ago as the Nederlandsche Gist- en Spiritusfabriek, and later known as Gist Brocades and DSM Sinochem Pharmaceuticals, Centrient Pharmaceuticals is headquartered in Rotterdam, Netherlands, with manufacturing facilities and commercial operations across China, India, the Netherlands, Spain, the United States, and Mexico. The company is owned by Bain Capital Private Equity and remains committed to quality, reliability, sustainability, and the fight against antimicrobial resistance.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
